Press Release: intomics : Intomics welcomes new international collaborator in its client portfolio

Intomics A/S enters a new collaboration with a leading Swiss-based biopharmaceutical company to accelerate a better understanding of the pathological processes underlying human neurodegenerative diseases at the molecular level through systems biology.Intomics A/S and Actelion Pharmaceuticals Ltd have entered a new collaboration with the aim of developing a systems biology view of neurodegeneration. Intomics will assist Actelion with expertise, experience and tools in analyzing and advancing knowledge based on data specifically related to neurodegeneration. The... Source: RealWire